ICUI ICU Medical (ICUI) Q1 FY26 earnings call
ICU Medical delivered solid Q1 FY26 results, marked by strong organic growth in its core IV Systems business and sequential gross margin expansion. While facing headwinds from the IV Solutions deconsolidation and increased logistics costs, the company reaffirmed its full-year guidance, anticipating offsets from lower tariffs and accelerated operational efficiencies. Management is focused on deleveraging and exploring strategic options for the Vital Care portfolio.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
ICUI operating KPIs by quarter
| KPI | This call Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Capital expenditures General maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the US | $11MDuring the quarter, we invested $9 million of cash spend for quality system and product-related remediation activities, $17 million on restructuring and integration and $11 million on CapEx for general maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the USSource: earnings call transcript | $19MDuring the quarter, we invested $11 million of cash spend for quality system and product-related remediation activities, $11 million on restructuring and integration and $19 million on CapEx for general maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the USSource: earnings call transcript | +72.7% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.